trial · primary record
Zolbetuximab
Advanced Biliary Tract Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2030-08 |
| Primary endpoint | Progression free survival (PFS) rate |
| Registry ID | NCT07723534 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:21.426Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07723534
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.